logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Esther Sanfeliu

university of barcelona
H指数:19
被引数:2,739

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer

免疫和增殖基因特征及基质肿瘤浸润淋巴细胞与I期三阴性乳腺癌患者临床结局的关联

European Journal of Cancer
IF7.1
2026-09-040
PRE
Paolo Tarantino; Tianyu Li; Laia Paré Brunet; Esther Sanfeliu; Beyza Koca; Ruby Guo; Marta Ollé-Monge; Olga Martínez-Sáez; Olivia Cunningham; Melissa E. Hughes; Ashka Patel; Tari A. King; Elizabeth A. Mittendorf; Nancy U. Lin; Fara Brasó-Maristany; Guillermo Villacampa; Patricia Villagrasa; Nabihah Tayob; Aleix Prat; Sara M. Tolaney
HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX在HER2阳性早期乳腺癌老年患者中的应用：来自RESPECT试验中曲妥珠单抗±化疗的扩展随访研究

Nature Communications
IF15.7
2025-11-040
OAAI
Kazuki Nozawa; Masataka Sawaki; Yukari Uemura; Michiko Tsuneizumi; Toshimi Takano; Naomi Gondo; Fumikata Hara; Michiko Harao; Tatsuya Toyama; Naruto Taira; Ana Vivancos; Charles M. Perou; Esther Sanfeliu; Fara Brasó-Maristany; Joel S. Parker; Wesley Buckingham; Laia Paré; Guillermo Villacampa; Mercedes Marín-Aguilera; Patricia Villagrasa; Aleix Prat; Hiroji Iwata
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy

Ki67动态变化可预测接受术前内分泌治疗的雌激素受体阳性/HER2阴性乳腺癌患者的内分泌敏感性。

ESMO Open
IF8.3
2025-10-160
OAAI
R. Gómez-Bravo; B. Walbaum; M. Bergamino; O. Martínez-Sáez; F. Schettini; E. Seguí; I. García-Fructuoso; T. Pascual; N. Chic; M. González; A. Rodríguez; M. Rey; P. Giménez-Xavier; P. Blasco; O. Castillo; P. Galván; E. Sanfeliu; B. González-Farré; M. Vidal; B. Adamo; F. Brasó-Maristany; A. Prat; M. Muñoz
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

PD1疗法在PD1高表达mRNA肿瘤中的疗效：SOLTI-1904 ACROPOLI II期试验中队列1和队列2的结果

ESMO Open
IF8.3
2025-09-300
OAAI
E. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer

雌激素受体阳性、HER2阴性乳腺癌年轻女性的基因组与临床特征

ESMO Open
IF8.3
2025-09-240
PREAI
B. Walbaum; O. Martínez-Sáez; F. Brasó-Maristany; E. Seguí; N. Chic; J. Muñoz i Carrillo; J. Antonio Sola; M. Rey; P. Giménez-Xavier; R. Gómez-Bravo; I. García-Fructuoso; T. Pascual; A. Rodriguez-Hernandez; F. Schettini; M. Bergamino; M. González; L. Angelats; B. Adamo; M. Muñoz; E. Sanfeliu; A. Martínez-Pozo; P. Galván; P. Jares; J.A. Puig-Butillé; I. Cebrecos; C. Sánchez; A. Prat; M. Vidal
Preoperative Radiotherapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results from the YOUNGSTER Trial

术前放疗诱导的分子和免疫调控在早期乳腺癌中的作用：YOUNGSTER试验的结果

international journal of radiation oncology biology physics
IF0
2025-08-050
OA
Carles Gomà; Meritxell Mollà; Gabriela Oses; Esther Sanfeliu; Adela Rodríguez-Hernández; Blanca González-Farré; Patricia Galván; Valeria Sirenko; Oleguer Castillo; Paula Blasco; Alba Llop-Guevara; Violeta Serra; Sergi Ganau; Belén Úbeda; Xavier Bargalló; Carla Cases; Artur Latorre-Musoll; Olga Martínez-Sáez; Isabel Garcia-Fructuoso; Raquel Gómez-Bravo; Francesco Schettini; Barbara Adamo; Tomás Pascual; Maria Vidal; Montserrat Muñoz; Maria Laplana; Isaac Cebrecos; Eduard Mension; Aleix Prat; Fara Brasó-Maristany
Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review

紫杉醇相关性Kounis综合征I型：1例年轻HER2阳性乳腺癌患者报告及基因组学在阐明复杂治疗情境中作用：病例报告及综述

BREAST
IF7.9
2025-06-010
OAAI
Munoz, Javier; Nucera, Sabrina; Garcia, Nuria Rubira; Cebrecos, Isaac; Oses, Gabriela; Ganau, Sergi; Sanfeliu, Esther; Jares, Pedro; Marin-Aguilera, Mercedes; Galvan, Patricia; Braso-Maristany, Fara; Martinez-Saez, Olga; Cascos, Enric; Font, Carme; Schettini, Francesco
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab

HER2DX ERBB2 mRNA评分：用于接受化疗、曲妥珠单抗和帕妥珠单抗治疗的一线晚期HER2阳性乳腺癌

NPJ BREAST CANCER
IF7.6
2025-04-250
OA
Sanchez-Bayona, Rodrigo; Martinez-Saez, Olga; Romero-Romero, Denys; Segui, Elia; Carcelero, Esther; Tolosa, Pablo; Soberino, Jesus; Alva, Manuel; Pascual, Tomas; Lema, Laura; Garcia-Fructuoso, Isabel; Cobos-Fernandez, Maria Angeles; Rey, Maria; Manso, Luis; Aguirre, Angela; Madariaga, Ainhoa; Sirenko, Valeria; Gonzalez-Deza, Cristina; Blasco, Paula; Mayhua, Astrid; Castillo, Oleguer; Galvan, Patricia; Sanfeliu, Esther; Villacampa, Guillermo; Buckingham, Wesley; Marin-Aguilera, Mercedes; Pare, Laia; Villagrasa, Patricia; Perou, Charles M.; Maues, Julia; Braso-Maristany, Fara; Ciruelos, Eva
Correlation of the HER2DX Genomic Test withPathologic Features in Early-Stage HER2+BreastCancer
LABORATORY INVESTIGATION
IF4.2
2025-03-010
PRE
Sanfeliu, Esther; Martinez-Romero, Anabel; Marin-Aguilera, Mercedes; Gonzalez-Farre, Blanca; Galvan, Patricia; Infantes, Angela Aguirre; Alarcon, Valeria Sirenko; Blasco, Paula; Castillo, Oleguer; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butille, Joan Anton; Martinez, Antonio; Munoz, Montserrat; Losada, MariaVidal; Pascual, Tomas; Martinez, Olga; Solis, Elia Segui; Garcia-Fructuoso, Isabel; Cejalvo, Juan Miguel; Ciruelos, Eva; Brunet, Laia Pare; Vivancos, Ana; Villagrasa, Patricia; Buckingham, Wesley; Parker, Joel; Braso-Maristany, Fara; Prat, Aleix
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

早期三阴性乳腺癌经新辅助紫杉烷类药物治疗后的TNBC-DX基因组检测

ANNALS OF ONCOLOGY
IF65.4
2025-02-014
OAAI
Martin, M.; Stecklein, S. R.; Gluz, O.; Villacampa, G.; Monte-Millan, M.; Nitz, U.; Cobo, S.; Christgen, M.; Braso-Maristany, F.; Alvarez, E. L.; Echavarria, I.; Conte, B.; Kuemmel, S.; Bueno-Muino, C.; Jerez, Y.; Kates, R.; Cebollero, M.; Kolberg-Liedtke, C.; Bueno, O.; Garcia-Saenz, J. a.; Moreno, F.; Grischke, E. -m.; Forstbauer, H.; Braun, M.; Warm, M.; Hackmann, J.; Uleer, C.; Aktas, B.; Schumacher, C.; Wuerstleins, R.; Graeser, M.; zu Eulenburg, C.; Kreipe, H. H.; Gomez, H.; Massarrah, T.; Herrero, B.; Pare, L.; Bohn, U.; Lopez-Tarruella, S.; Vivanco, A.; Sanfeliu, E.; Parker, J. S.; Perou, C. M.; Villagrasa, P.; Prat, A.; Sharma, P.; Harbeck, N.
HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers5
ESMO OPEN
IF8.3
2025-02-010
PRE
Lynce, F.; Martinez-Saez, O.; Walbaum, B.; Braso-Maristany, F.; Waks, A. G.; Villagrasa, P.; Javierre, G. Villacampa; Sanfeliu, E.; Galvan, P.; Pare, L.; Anderson, L. M.; Perou, C. M.; Parker, J. S.; Vivancos, A.; Dilullo, M. K.; Pernas, S.; Winer, E. P.; Overmoyer, B.; Mittendorf, E. A.; Bueno-Muino, C.; Martin, M.; Prat, A.; Tolaney, S. M.
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer
ESMO OPEN
IF8.3
2025-01-010
OAAI
Angelats, L.; Pare, L.; Rubio-Perez, C.; Sanfeliu, E.; Gonzalez, A.; Segui, E.; Villacampa, G.; Marin-Aguilera, M.; Pernas, S.; Conte, B.; Albarran-Fernandez, V.; Martinez-Saez, O.; Aguirre, A.; Galvan, P.; Fernandez-Martinez, A.; Cobo, S.; Rey, M.; Martinez-Romero, A.; Walbaum, B.; Schettini, F.; Vidal, M.; Buckingham, W.; Munoz, M.; Adamo, B.; Agrawal, Y.; Guedan, S.; Pascual, T.; Agudo, J.; Grzelak, M.; Borcherding, N.; Heyn, H.; Vivancos, A.; Parker, J. S.; Villagrasa, P.; Perou, C. M.; Prat, A.; Braso-Maristany, F.
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
NATURE COMMUNICATIONS
IF15.7
2024-07-111
OAAI
Braso-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martinez-Saez, Olga; Cejalvo, Juan Miguel; Margeli, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Odena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana Maria; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sanchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martin; Izarzugaza, Yann; Galvan, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomas; Prat, Aleix; Oliveira, Mafalda
Characterizing Immune Infiltration in Metastatic Hormone Receptor-Positive/HER2Negative Breast Cancer: A Comprehensive Translational Analysis from four SOLTI Clinical Trials
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Segui, Elia; Sanfeliu, Esther; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Salvador, Fernando; Angelats, Laura; Villanueva, Lorea; Espinosa, Alejandra; Galvan, Patricia; Fernandez, Esther; Gonzalez-Farre, Xavier; Escriva-De-Romani, Santiago; Chic, Nuria; Ciruelos, Eva; Saura, Cristina; Manso, Luis; Oliveira, Mafalda; Tabernero, Josep; Prat, Aleix; Pascual, Tomas
Immunologic features and association with prognosis in hormone receptor positive/HER2-negative (HR+/HER2) metastatic breast cancer (MBC) treated with chemotherapy (CT) or CDK4/6-inhibitors (CDK4/6i) + endocrine therapy (ET)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Schettini, Francesco; Palleschi, Michela; Mannozzi, Francesca; Braso-Maristany, Fara; Cecconetto, Lorenzo; Galvan, Patricia; Mariotti, Marita; Ferrari, Alessia; Scarpi, Emanuela; Miserocchi, Anna; Nanni, Oriana; Sanfeliu, Esther; Prat, Aleix; Rocca, Andrea; De Giorgi, Ugo
Investigating HER2DX genomic assay concordance within HER2-positive breast cancer
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Braso-Maristany, Fara; Pare, Laia; Villacampa, Guillermo; Marin-Aguilera, Mercedes; Spellman, Paul; Waks, Adrienne; Krop, Ian; Sanfeliu, Esther; Li, Zhequi; Galvan, Patricia; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butille, Joan Anton; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Tolaney, Sara; Metzger, Otto; Polyak, Kornelia; Prat, Aleix
Targeting PAM50 HER2-Enriched intrinsic subtype with enzalutamide in hormone receptor- positive/HER2-negative (HR+/HER2-) advanced breast cancer: results of the SOLTI-1502 ARIANNA trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Oliveira, Mafalda; Pascual, Tomas; Pernas, Sonia; Margeli, Mireia; Blanch, Salvador; Adamo, Barbara; Bofill, Francisco Javier Salvador; Gonzalez-Farre, Xavier; Chillara, Samyukta; Galvan, Patricia; Sanfeliu, Esther; Blasco, Paula; Sirenko, Valeria; Espinosa, Alejandra; Perou, Charles M.; Prat, Aleix; Manso, Luis

研究方向

暂未获取到该数据
A
Aleix Prat
H 指数:92论文数:1,351被引数:3.6万
T
Tomás Pascual
H 指数:35论文数:449被引数:5,517
F
Fara Brasó‐Maristany
H 指数:28论文数:304被引数:3,798
B
Blanca González‐Farré
H 指数:34论文数:200被引数:5,266
P
Patricia Galván
H 指数:37论文数:313被引数:6,544
M
María Vidal
H 指数:43论文数:425被引数:1.1万
O
Olga Martínez‐Sáez
H 指数:20论文数:172被引数:2,745
F
Francesco Schettini
H 指数:32论文数:336被引数:4,636
M
Montserrat Muñoz-Mateu
H 指数:50论文数:620被引数:9,881
L
Laia Paré
H 指数:43论文数:431被引数:7,309